MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on December 15, 2006; DOI: 10.1124/mol.106.030718


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.030718v1
71/3/736    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
Joaquin Jordan
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gomez-Lazaro, M.
Right arrow Articles by Jordan, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gomez-Lazaro, M.
Right arrow Articles by Jordan, J.


Received for publication September 8, 2006.
Revised November 7, 2006.
Accepted for publication December 15, 2006.

REACTIVE OXYGEN SPECIES AND P38 MAPK ACTIVATE BAX TO INDUCE MITOCHONDRIAL CYTOCHROME C RELEASE AND APOPTOSIS IN RESPONSE TO MALONATE

Maria Gomez-Lazaro 1, Maria F Galindo 1, Raquel M Melero-Fernandez de Mera 1, Francisco J Fernandez-Gomez 1, Caoimhin Concannon 2, Miguel F Segura 3, Joan X Comella 3, Jochen HM Prehn 2, Joaquin Jordan 4*

1 UCLM-CRIB 2 Royal College of Surgeons in Ireland 3 University of Lleida 4 Universidad Castilla La Mancha-CRIB

* Address correspondence to: E-mail: joaquin.jordan{at}uclm.es

Abstract

Malonate, an inhibitor of mitochondrial complex II, is a widely used toxin to study neurodegeneration in Huntington's disease and ischemic stroke. We have previously shown that malonate increased reactive oxygen species (ROS) production in human SH-SY5Y neuroblastoma cells, leading to oxidative stress, cytochrome-c release, and apoptotic cell death. Expression of a Green Fluorescent Protein-Bax fusion protein in SH-SY5Y neuroblastoma cells demonstrated a Bax redistribution from the cytosol to mitochondria after 12 - 24 h of malonate treatment that coincided with mitochondrial potential collapse and chromatin condensation. Inhibition of Bax translocation using furosemide, as well as Bax gene deletion afforded significant protection against malonate-induced apoptosis. Further experiments revealed that malonate induced a prominent increase in the level of activated p38 MAP kinase, and that treatment with the p38 MAP kinase inhibitor SKF86002 potently blocked malonate-induced Bax translocation and apoptosis. Treatment with vitamin E diminished ROS production, reduced the activation status of p38 MAP kinase, inhibited Bax translocation and protected against malonate-induced apoptosis. Our data suggest that malonate-induced ROS production and subsequent p38 MAP kinase activation mediates the activation of the pro-apoptotic Bax protein to induce mitochondrial membrane permeabilisation and neuronal apoptosis.


Key words: P38 MAP Kinase, Fluorescence techniques, Regulation - post-transcriptional, Apoptosis, Oxidative stress/antioxidants


This article has been cited by other articles:


Home page
Cancer Res.Home page
A. M. Cervera, N. Apostolova, F. L. Crespo, M. Mata, and K. J. McCreath
Cells Silenced for SDHB Expression Display Characteristic Features of the Tumor Phenotype
Cancer Res., June 1, 2008; 68(11): 4058 - 4067.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
G. Sheng, J. Guo, and B. W. Warner
Epidermal growth factor receptor signaling modulates apoptosis via p38{alpha} MAPK-dependent activation of Bax in intestinal epithelial cells
Am J Physiol Gastrointest Liver Physiol, September 1, 2007; 293(3): G599 - G606.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics